Nashville-based pharmaceutical company will acquire U.S. rights from Japan-based Kyowa Kirin
SANCUSO® is an established, FDA-Approved Oncology Supportive Care Medicine
PR Newswire
NASHVILLE, Tenn. and BEDMINSTER, N.J., Jan. 4, 2022
PR Newswire
NASHVILLE, Tenn. and BEDMINSTER, N.J., Jan. 4, 2022
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey